RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM

NCT00805961 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

RADIATION: Radiation therapy
DRUG: Temozolomide
DRUG: Bevacizumab
DRUG: Bevacizumab
DRUG: Everolimus

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]